PRIME FOCUS Financial Statement Analysis
|
||
|
The Revenues of PRIME FOCUS have increased by 13.60% YoY .
The Earnings Per Share (EPS) of PRIME FOCUS has decreased by Negative YoY. |
||
PRIME FOCUS Last 5 Annual Financial Results
[BOM: 532748|NSE : PFOCUS]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Operating Income | ₹2,221,329,972 Cr | ₹1,955,384,607 Cr | ₹1,955,384,607 Cr | ₹1,955,384,607 Cr | ₹1,955,384,607 Cr |
| Operating Expenses | ₹343,392,228 Cr | ₹256,318,314 Cr | ₹256,318,314 Cr | ₹256,318,314 Cr | ₹256,318,314 Cr |
| Expenses | ₹1,538,985,194 Cr | ₹1,393,671,303 Cr | ₹1,393,671,303 Cr | ₹1,393,671,303 Cr | ₹1,393,671,303 Cr |
| Operating Profit (Excl OI) | ₹682,344,778 Cr | ₹561,713,304 Cr | ₹561,713,304 Cr | ₹561,713,304 Cr | ₹561,713,304 Cr |
| Other Income | ₹94,285,195 Cr | ₹81,328,011 Cr | ₹81,328,011 Cr | ₹81,328,011 Cr | ₹81,328,011 Cr |
| Interest | ₹109,735,176 Cr | ₹67,109,999 Cr | ₹67,109,999 Cr | ₹67,109,999 Cr | ₹67,109,999 Cr |
| Depreciation | ₹289,212,395 Cr | ₹232,493,763 Cr | ₹232,493,763 Cr | ₹232,493,763 Cr | ₹232,493,763 Cr |
| Profit Before Tax | ₹319,755,553 Cr | ₹318,054,096 Cr | ₹318,054,096 Cr | ₹318,054,096 Cr | ₹318,054,096 Cr |
| Profit After Tax | ₹317,589,358 Cr | ₹225,166,203 Cr | ₹225,166,203 Cr | ₹225,166,203 Cr | ₹225,166,203 Cr |
| Consolidated Net Profit | ₹339,814,405 Cr | ₹213,705,117 Cr | ₹213,705,117 Cr | ₹213,705,117 Cr | ₹213,705,117 Cr |
| Earnings Per Share (Rs) | ₹-12.57 | ₹-13.49 | ₹4.92 | ₹-5.73 | ₹-1.45 |
| PAT Margin (%) | -12.73 | -12.37 | 4.19 | -5.14 | -2.21 |
| ROE(%) | -102.82 | -1,469.14 | 0.00 | 0.00 | -65.34 |
| ROCE(%) | 2.74 | -0.69 | 20.76 | 9.36 | 7.42 |
| Total Debt/Equity(x) | 7.31 | 11.85 | -14.65 | -20.21 | 187.88 |
Key Financials |
||
| Market Cap | : | ₹ 21,888.2 Cr |
| Revenue (TTM) | : | ₹ 4,919.5 Cr |
| Net Profit(TTM) | : | ₹ 145.7 Cr |
| EPS (TTM) | : | ₹ 1.9 |
| P/E (TTM) | : | 150.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PRIME FOCUS | -5.9% | 4.7% | 84.4% |
| SAGILITY | -2% | 2.4% | -4.3% |
| SYNGENE INTERNATIONAL | 0.1% | -3.2% | -42.9% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | -4.6% | 0.3% | -6.1% |
| INDEGENE | 5% | 10.7% | -3.2% |
| NESCO | 0.1% | -3.7% | -22.8% |
| LATENT VIEW ANALYTICS | NA | -2.9% | -27.2% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -5.9% | -20.8% | 40% |
| CMS INFO SYSTEMS | -2.9% | -2.6% | -37.5% |
PRIME FOCUS Revenues
[BOM: 532748|NSE : PFOCUS]
| Y-o-Y | 13.60 % |
| 5 Yr CAGR | 3.24 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,221,329,972 Cr | 13.60 | |
| Mar2024 | ₹1,955,384,607 Cr | 0.00 | |
| Mar2023 | ₹1,955,384,607 Cr | 0.00 | |
| Mar2022 | ₹1,955,384,607 Cr | 0.00 | |
| Mar2021 | ₹1,955,384,607 Cr | - | |
PRIME FOCUS Operating Profit
[BOM: 532748|NSE : PFOCUS]
| Y-o-Y | 21.48 % |
| 5 Yr CAGR | 4.98 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹682,344,778 Cr | 21.48 | |
| Mar2024 | ₹561,713,304 Cr | 0.00 | |
| Mar2023 | ₹561,713,304 Cr | 0.00 | |
| Mar2022 | ₹561,713,304 Cr | 0.00 | |
| Mar2021 | ₹561,713,304 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 6.93 % |
| 5 Yr CAGR | 1.69 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 30.72% | 6.93 | |
| Mar2024 | 28.73% | 0.00 | |
| Mar2023 | 28.73% | 0.00 | |
| Mar2022 | 28.73% | 0.00 | |
| Mar2021 | 28.73% | - | |
PRIME FOCUS Profit After Tax
[BOM: 532748|NSE : PFOCUS]
| Y-o-Y | 59.01 % |
| 5 Yr CAGR | 12.29 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹339,814,405 Cr | 59.01 | |
| Mar2024 | ₹213,705,117 Cr | 0.00 | |
| Mar2023 | ₹213,705,117 Cr | 0.00 | |
| Mar2022 | ₹213,705,117 Cr | 0.00 | |
| Mar2021 | ₹213,705,117 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | -12.73 % | Negative | |
| Mar2024 | -12.37 % | Negative | |
| Mar2023 | 4.19 % | Positive | |
| Mar2022 | -5.14 % | Negative | |
| Mar2021 | -2.21 % | - | |
PRIME FOCUS Earnings Per Share (EPS)
[BOM: 532748|NSE : PFOCUS]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹-13 | Negative | |
| Mar2024 | ₹-13 | Negative | |
| Mar2023 | ₹4.92 | Positive | |
| Mar2022 | ₹-5.73 | Negative | |
| Mar2021 | ₹-1.45 | - | |
PRIME FOCUS Return on Capital Employed (ROCE)
[BOM: 532748|NSE : PFOCUS]
| Y-o-Y | Positive |
| 5 Yr CAGR | -22.05 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 2.74% | Positive | |
| Mar2024 | -0.69% | Negative | |
| Mar2023 | 20.76% | 121.79 | |
| Mar2022 | 9.36% | 26.15 | |
| Mar2021 | 7.42% | - | |
PRIME FOCUS Share Price vs Sensex
| Current Share Price | : | ₹281.1 |
| Current MarketCap | : | ₹ 21,888.2 Cr |
| Updated EOD on | : | Aug 11,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PRIME FOCUS | -5.9% |
4.7% |
84.4% |
| SENSEX | -0.4% |
0.8% |
-3% |
PRIME FOCUS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 500 MOMENTUM 50 | 1.5% | 2.9% | NA |
| BSE 250 SMALLCAP INDEX | 1.2% | 1.5% | 7.5% |
| BSE CONSUMER DISCRETIONARY & SERVICES | 1.2% | 5.5% | 10.1% |
| BSE 400 MIDSMALLCAP INDEX | 0.9% | 1.6% | 9.4% |
| BSE 1000 | 0.3% | 1.5% | 4.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 500 | 1.2% | 1.7% | NA |
| NIFTY SMALLCAP 250 | 1% | 1.5% | 9% |
| NIFTY MIDSMALLCAP 400 | 0.7% | 1.3% | 10.4% |
| NIFTY TOTAL MARKET | 0% | 1.5% | 4.7% |
| NIFTY 500 | -0% | 1.4% | 4.4% |
You may also like the below Video Courses
FAQ about PRIME FOCUS Financials
How the annual revenues of PRIME FOCUS have changed ?
The Revenues of PRIME FOCUS have increased by 13.60% YoY .
How the Earnings per Share (EPS) of PRIME FOCUS have changed?
The Earnings Per Share (EPS) of PRIME FOCUS has decreased by Negative YoY .
Check out Intrinsic Value of Peers of PRIME FOCUS
Compare Stock Analytics of Peers of PRIME FOCUS
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
